1 / 3

Enhancing Drug Disease Models: Insights and Recommendations

This document outlines key questions posed to the committee regarding the improvement of mathematical, statistical, and clinical concepts in drug disease models. It seeks to gather insights on how these models can be utilized effectively to advance drug development and explore further research opportunities in this domain. The committee's feedback is essential for refining methodologies and ensuring that drug disease models contribute positively to the pharmaceutical landscape.

johnda
Télécharger la présentation

Enhancing Drug Disease Models: Insights and Recommendations

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Disease Models: Questions • 1.  What comments or suggestions does the committee have for improving the mathematical, statistical or clinical concepts in the model? Gobburu, Pharmacometrics

  2. Disease Models: Questions • 2.  How does the committee envision such a model can be best utilized to improve drug development? Gobburu, Pharmacometrics

  3. Disease Models: Questions • 3. Does the committee have any general recommendations for further exploratory research into drug disease models?  Gobburu, Pharmacometrics

More Related